# Daniel E. Fürst

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-e-furst/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,727 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 82 |
| i10-index | 239 |
| Last Known Institution | University of California, Los Angeles |
| OpenAlex ID | https://openalex.org/A5052078671 |
| ORCID iD | https://orcid.org/0000-0002-4018-7629 |
| Works | 363 |

## Researcher papers

- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [American college of rheumatology preliminary definition of improvement in rheumatoid arthritis](https://scholariq.org/papers/american-college-of-rheumatology-preliminary-definition-of-improvement-in/)
- [Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial](https://scholariq.org/papers/infliximab-chimeric-anti-tumour-necrosis-factor-monoclonal-antibody-versus/)
- [2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis](https://scholariq.org/papers/2012-update-of-the-2008-american-college-of-rheumatology-recommendations-for-the/)
- [Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)](https://scholariq.org/papers/sustained-benefits-of-infliximab-therapy-for-dermatologic-and-articular/)
- [Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events](https://scholariq.org/papers/low-dose-long-term-corticosteroid-therapy-in-rheumatoid-arthritis-an-analysis-of/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

## Researcher university

- [University of California, Los Angeles](https://scholariq.org/institutions/university-of-california-los-angeles/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.